tiprankstipranks
Trending News
More News >
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market
Advertisement

Pharmarise Holdings Corp. (2796) Ratios

Compare
0 Followers

Pharmarise Holdings Corp. Ratios

JP:2796's free cash flow for Q2 2024 was ¥0.14. For the 2024 fiscal year, JP:2796's free cash flow was decreased by ¥ and operating cash flow was ¥<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
1.15 1.16 1.28 1.12 1.06
Quick Ratio
0.72 0.92 1.01 0.85 0.80
Cash Ratio
0.22 0.48 0.47 0.49 0.45
Solvency Ratio
0.02 0.09 0.10 0.10 0.09
Operating Cash Flow Ratio
0.04 0.26 0.08 0.21 0.16
Short-Term Operating Cash Flow Coverage
0.17 0.72 0.31 0.76 0.56
Net Current Asset Value
¥ -12.16B¥ -5.06B¥ -6.17B¥ -7.85B¥ -8.59B
Leverage Ratios
Debt-to-Assets Ratio
0.46 0.39 0.42 0.43 0.45
Debt-to-Equity Ratio
2.05 1.33 1.50 1.72 1.90
Debt-to-Capital Ratio
0.67 0.57 0.60 0.63 0.66
Long-Term Debt-to-Capital Ratio
0.63 0.43 0.52 0.54 0.56
Financial Leverage Ratio
4.48 3.40 3.59 3.97 4.27
Debt Service Coverage Ratio
0.51 0.55 0.84 0.69 0.70
Interest Coverage Ratio
1.42 26.15 23.38 16.61 13.97
Debt to Market Cap
2.54 1.52 1.38 1.39 1.66
Interest Debt Per Share
1.26K 977.92 1.07K 1.16K 1.20K
Net Debt to EBITDA
7.92 1.65 2.09 2.35 2.98
Profitability Margins
Gross Profit Margin
13.58%15.63%15.73%15.42%14.58%
EBIT Margin
-0.83%2.12%2.69%2.44%1.75%
EBITDA Margin
2.51%5.12%5.48%4.95%4.44%
Operating Profit Margin
0.25%2.76%2.95%2.38%2.03%
Pretax Profit Margin
-1.07%2.02%2.56%2.30%1.60%
Net Profit Margin
-1.33%0.64%0.87%0.81%1.13%
Continuous Operations Profit Margin
-1.35%0.67%0.89%0.80%1.14%
Net Income Per EBT
124.22%31.74%33.81%35.44%70.45%
EBT Per EBIT
-432.21%72.95%86.97%96.47%79.21%
Return on Assets (ROA)
-2.57%1.42%1.88%1.72%2.29%
Return on Equity (ROE)
-11.27%4.84%6.77%6.85%9.77%
Return on Capital Employed (ROCE)
0.72%10.58%9.95%8.13%6.82%
Return on Invested Capital (ROIC)
0.81%2.76%2.97%2.40%4.02%
Return on Tangible Assets
-3.40%1.65%2.22%2.10%2.90%
Earnings Yield
-14.28%5.80%6.58%5.91%9.21%
Efficiency Ratios
Receivables Turnover
12.51 86.00 107.74 56.51 53.32
Payables Turnover
8.79 10.32 10.58 9.60 8.40
Inventory Turnover
11.69 19.17 18.89 17.11 16.49
Fixed Asset Turnover
8.24 8.66 8.12 8.13 8.06
Asset Turnover
1.94 2.22 2.17 2.12 2.02
Working Capital Turnover Ratio
20.11 26.42 29.03 58.33 114.16
Cash Conversion Cycle
18.86 -12.07 -11.78 -10.22 -14.49
Days of Sales Outstanding
29.17 4.24 3.39 6.46 6.85
Days of Inventory Outstanding
31.22 19.04 19.32 21.34 22.14
Days of Payables Outstanding
41.52 35.36 34.48 38.01 43.47
Operating Cycle
60.38 23.29 22.71 27.80 28.98
Cash Flow Ratios
Operating Cash Flow Per Share
37.59 268.07 76.41 209.02 166.28
Free Cash Flow Per Share
30.76 210.41 26.47 149.70 117.94
CapEx Per Share
6.82 57.66 49.94 59.32 48.34
Free Cash Flow to Operating Cash Flow
0.82 0.78 0.35 0.72 0.71
Dividend Paid and CapEx Coverage Ratio
5.51 3.74 1.19 2.86 2.68
Capital Expenditure Coverage Ratio
5.51 4.65 1.53 3.52 3.44
Operating Cash Flow Coverage Ratio
0.03 0.28 0.07 0.18 0.14
Operating Cash Flow to Sales Ratio
<0.01 0.05 0.01 0.04 0.03
Free Cash Flow Yield
6.24%34.44%3.64%19.32%17.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.00 17.25 15.20 16.93 10.86
Price-to-Sales (P/S) Ratio
0.09 0.11 0.13 0.14 0.12
Price-to-Book (P/B) Ratio
0.81 0.83 1.03 1.16 1.06
Price-to-Free Cash Flow (P/FCF) Ratio
16.03 2.90 27.50 5.18 5.62
Price-to-Operating Cash Flow Ratio
13.12 2.28 9.53 3.71 3.99
Price-to-Earnings Growth (PEG) Ratio
0.84 -0.66 3.28 -0.68 <0.01
Price-to-Fair Value
0.81 0.83 1.03 1.16 1.06
Enterprise Value Multiple
11.62 3.81 4.49 5.13 5.75
Enterprise Value
17.60B 10.14B 12.71B 13.30B 13.02B
EV to EBITDA
11.62 3.81 4.49 5.13 5.75
EV to Sales
0.29 0.19 0.25 0.25 0.26
EV to Free Cash Flow
50.37 5.13 51.47 9.55 11.68
EV to Operating Cash Flow
41.23 4.02 17.83 6.84 8.29
Tangible Book Value Per Share
-51.49 397.53 329.00 200.74 69.60
Shareholders’ Equity Per Share
611.57 731.98 708.04 668.53 624.62
Tax and Other Ratios
Effective Tax Rate
-0.26 0.67 0.65 0.65 0.29
Revenue Per Share
5.31K 5.53K 5.53K 5.62K 5.40K
Net Income Per Share
-70.42 35.42 47.90 45.78 61.03
Tax Burden
1.24 0.32 0.34 0.35 0.70
Interest Burden
1.28 0.95 0.95 0.94 0.92
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.00 0.00 0.00 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 <0.01
Income Quality
-0.58 2.40 0.54 1.62 1.92
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis